• Publications
  • Influence
Incidence and consequences of post-transplantation lymphoproliferative disorders.
Post-transplant lymphoproliferative disorder (PTLD) is a recognized severe complication arising in allograft recipients treated with immunosuppressive drugs. Although not common, PTLD is one of theExpand
  • 160
  • 4
Incidence of Renal and Liver Rejection and Patient Survival Rate Following Combined Liver and Kidney Transplantation
Multiple organ transplantations are used to treat chronic multiple organ failure. However, long‐term mortality and graft tolerance remain to be evaluated. We carried out a retrospective andExpand
  • 99
  • 4
Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade.
AIMS Belatacept is a new recombinant molecule (CTLA4-Ig) that interferes with the second activation signal of T lymphocytes. CTLA4-Ig induced T cell allograft tolerance in rodents but not inExpand
  • 63
  • 4
Human parvovirus B19 infection in organ transplant recipients
We report a 61‐yr‐old kidney transplant recipient with human Parvovirus B19 (HPV B19) infection presenting as a severe pancytopenia 1 month after transplantation. Bone marrow aspiration revealedExpand
  • 74
  • 3
Post-transplantation polyomavirus infections.
Increasing attention has been recently accorded to BK and JC viruses (BKV and JCV). Both these human polyomavirus (HPV) are members of the papovavirus family which includes the simian virus SV 40.Expand
  • 62
  • 1
Single-center experience with cyclosporine therapy for kidney transplantation: analysis of a twenty-year period in 1200 patients.
Since the introduction of cyclosporine (CyA) in our center in February 1983, 1267 kidney transplant patients have received an immunosuppressive regimen based on CyA, usually in association withExpand
  • 15
  • 1